Related Experiment Video
Updated: Mar 6, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
miR-16 controls myoblast proliferation and apoptosis through directly suppressing Bcl2 and FOXO1 activities
Xinzheng Jia1, Hongjia Ouyang1, Bahareldin Ali Abdalla1
1Department of Animal Genetics, Breeding and Reproduction, College of Animal Science, South China Agricultural University, Guangzhou, Guangdong 510642, China; Guangdong Provincial Key Lab of Agro-Animal Genomics and Molecular Breeding, and Key Lab of Chicken Genetics, Breeding and Reproduction, Ministry of Agriculture, Guangzhou, Guangdong 510642, China.
Abstract:
Myogenesis mainly involves several steps including myoblast proliferation, differentiation, apoptosis and fusion. Except for muscle specific regulators, few miRNAs were proved to coordinate this complex process. Here, we reported that miR-16 inhibited myoblast proliferation and promoted myoblast apoptosis by directly targeting Bcl2 and FOXO1. The expression level of miR-16 was significantly decreased in the hypertrophic pectoral muscle compared to the normal pectoral muscle in chicken. In vitro, elevating miR-16 significantly inhibited myoblast proliferation and promoted myoblast apoptosis, resulting in about 11.2% cells arrested in G1 phase and 12.3% apoptotic cells in the early stage. Bioinformatic and biochemical analyses revealed Bcl2 and FOXO1 as direct targets of miR-16. Consist to the effect of miR-16 on myogenesis, specific inhibition of Bcl2 or FOXO1 significantly suppressed myoblast proliferation and induced myoblast apoptosis, indicating that both Bcl2 and FOXO1 contributed to miR-16 regulatory function in myogenesis. Interestingly, FOXO1, as the core target, mediated multiple growth-related pathways induced by miR-16 such as PI3K-AKT-MAPK and PI3K-AKT-mTOR. Chromatin immunoprecipitation coupled with high-throughput sequencing (ChIP-seq) revealed that 234 annotated genes bound by FOXO1 in the early-differentiated myoblasts, which were significantly enriched in myogenic proliferation, death and hypotrophy. Altogether, we proposed that miR-16 acted as a coordinated mediator to suppress myogenesis in avian through the control of myoblast proliferation and apoptosis. These findings have provided a novel mechanism whereby miR-16 represses Bcl2 and FOXO1 expression to maintain myoblast growth and skeletal muscle mass.
Insights
MicroRNA-16 (miR-16) suppresses avian myogenesis by inhibiting myoblast proliferation and promoting apoptosis. It targets Bcl2 and FOXO1, impacting muscle growth and mass.
Area of Science:
- Molecular Biology
- Developmental Biology
- Muscle Biology
Background:
- Myogenesis is a complex process involving myoblast proliferation, differentiation, apoptosis, and fusion.
- While muscle-specific regulators are known, few microRNAs (miRNAs) have been identified to coordinate these events.
- Understanding miRNA-mediated regulation is crucial for muscle development and mass maintenance.
Purpose of the Study:
- To investigate the role of miR-16 in avian myogenesis.
- To identify the direct molecular targets of miR-16 involved in muscle development.
- To elucidate the mechanism by which miR-16 regulates myoblast proliferation and apoptosis.
Main Methods:
- Quantitative analysis of miR-16 expression in chicken pectoral muscle.
- In vitro experiments to assess the effects of miR-16 on myoblast proliferation and apoptosis.
- Bioinformatic and biochemical analyses to identify direct targets of miR-16 (Bcl2 and FOXO1).
- Functional studies involving inhibition of Bcl2 and FOXO1.
- Chromatin immunoprecipitation coupled with high-throughput sequencing (ChIP-seq) to analyze FOXO1-bound genes.
Main Results:
- miR-16 expression was significantly decreased in hypertrophic pectoral muscle.
- Overexpression of miR-16 inhibited myoblast proliferation and promoted apoptosis in vitro.
- Bcl2 and FOXO1 were confirmed as direct targets of miR-16.
- Inhibition of Bcl2 or FOXO1 mimicked the effects of miR-16 on myogenesis.
- FOXO1 was identified as a core target mediating growth-related pathways (PI3K-AKT-MAPK, PI3K-AKT-mTOR).
- ChIP-seq identified 234 FOXO1-bound genes enriched in myogenic proliferation, death, and hypotrophy pathways.
Conclusions:
- miR-16 acts as a key regulator suppressing avian myogenesis.
- It controls myoblast proliferation and apoptosis by targeting Bcl2 and FOXO1.
- FOXO1 plays a central role in mediating miR-16's effects on myogenic pathways.
- This study reveals a novel mechanism for miR-16 in maintaining skeletal muscle mass.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs
MicroRNAs
The Intrinsic Apoptotic Pathway
Induced Pluripotent Stem Cells
Somatic...

